Moolec Science S.A.
MLEC · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,643 | $1,557 | $1,523 | $2,110 |
| % Growth | 69.7% | 2.2% | -27.8% | – |
| Cost of Goods Sold | $3,317 | $1,542 | $1,595 | $2,018 |
| Gross Profit | -$674 | $15 | -$72 | $92 |
| % Margin | -25.5% | 0.9% | -4.7% | 4.3% |
| R&D Expenses | $298 | $426 | $421 | $448 |
| G&A Expenses | $748 | $1,434 | $1,813 | $1,612 |
| SG&A Expenses | $900 | $1,615 | $1,995 | $1,840 |
| Sales & Mktg Exp. | $151 | $181 | $182 | $228 |
| Other Operating Expenses | $188 | $76 | $452 | -$154 |
| Operating Expenses | $1,385 | $2,116 | $2,868 | $2,134 |
| Operating Income | -$2,060 | -$2,101 | -$2,940 | -$2,042 |
| % Margin | -77.9% | -135% | -193% | -96.8% |
| Other Income/Exp. Net | -$87 | $158 | -$318 | $767 |
| Pre-Tax Income | -$2,146 | -$1,943 | -$3,258 | -$1,275 |
| Tax Expense | $281 | -$28 | -$723 | $127 |
| Net Income | -$2,427 | -$1,915 | -$2,536 | -$1,402 |
| % Margin | -91.8% | -123% | -166.5% | -66.5% |
| EPS | -0.06 | -0.05 | -0.07 | -0.04 |
| % Growth | -20% | 28.6% | -75% | – |
| EPS Diluted | -0.06 | -0.05 | -0.07 | -0.04 |
| Weighted Avg Shares Out | 38,961 | 38,683 | 36,220 | 37,767 |
| Weighted Avg Shares Out Dil | 38,961 | 38,683 | 36,220 | 37,767 |
| Supplemental Information | – | – | – | – |
| Interest Income | $393 | $385 | $349 | $561 |
| Interest Expense | $664 | $550 | $610 | $359 |
| Depreciation & Amortization | $299 | $325 | $284 | $289 |
| EBITDA | -$1,152 | -$1,069 | -$2,365 | -$627 |
| % Margin | -43.6% | -68.6% | -155.3% | -29.7% |